| Principal Photon Emissions | Energy (ke V) |
Photons per 100 Disintegrations |
| 133Ba (T1/2 = 10.5 years) | ||
| K |
30.97 | 63.4 |
| K |
30.62 | 34.2 |
| K |
35.0 | 22.8 |
| 53.15 | 2.14 | |
| 79.62 | 2.55 | |
| 80.99 | 33.0 | |
| 276.39 | 6.9 | |
| 302.83 | 17.8 | |
| 356.0 | 60.0 | |
| 383.85 | 8.7 | |
| 137Cs |
||
| K |
32.19 | 3.82 |
| K |
31.82 | 2.07 |
| K |
36.4 | 1.39 |
| Weighted Mean(4) | (32.9) | (7.28) |
| 661.6 | 89.98 | |
| 22Na (T1/2 = 2.60 years) | ||
| h |
511 | 179.80(5) |
| 1274.54 | 99.94 | |
| 60Co(T1/2 = 5.27 years) | ||
| 1173.2(6) | 100.0 | |
| 1332.5(6) | 100.0 | |
| 57Co(T1/2 = 270.9 days) | ||
| SXK | 7.0 | 56.0 |
| 14.4 | 9.5 | |
| 122.06 | 85.51 | |
| 136.47 | 10.60 | |
| Weighted Mean | (125.0) | (96.11) |
| ( |
||
| 54Mn (T1/2 = 312.7 days) | ||
| SXK | 6.0 | 25.0 |
| 834.83 | 99.98 | |
| 109Cd |
||
| K |
22.16 | 35.3 |
| K |
21.99 | 18.6 |
| K |
24.9 | 11.4 |
| Weighted Mean(4) | 63.5 | |
| 88.0 | 3.72 | |
| 129I(T1/2 = 1.57 × 107 years) | ||
| K |
29.78 | 37.0 |
| K |
29.46 | 20.0 |
| K |
13.2 | 37.0 |
| 39.58 | 7.52 | |
| Weighted Mean(4) | (31.3) | (77.80) |
|
(1)
In measurements for gamma- (or X-)ray assay purposes, fluorescent radiation from lead shielding (specifically, lead K X-rays
|
||
|
(2)
Only those photon emissions having an abundance
|
||
|
(3)
The K notation refers to X-ray emissions.
|
||
|
(4)
The weighted mean energies and total intensities are given for groups of photons that would not be resolved by a NaI(Tl) detector.
|
||
|
(5)
For this photon intensity to be usable, all emitted positrons must be annihilated in the source material.
|
||
|
(6)
Cascade.
|
||
| Topic/Question | Contact | Expert Committee |
| General Chapter | Ian DeVeau, Ph.D.
Director, Veterinary Drugs and Radiopharmaceuticals 1-301-816-8178 |
(RMI05) Radiopharmaceuticals and Medical Imaging Agents 05 |